Crystalline anti-human IL-12 antibodies
US8168760B2 · kind B2 · utility
12Cited by
38References
45Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 27, 2008 |
| Grant date | May 1, 2012 |
| Priority date | — |
| Expiry date | Nov 14, 2028 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to batch crystallization methods for crystallizing an anti-hIL-12 antibody that allows the production of the antibody on an industrial scale, antibody crystals obtained according to the methods, compositions containing the crystals, and methods of using the crystals and the compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.